Skip to main content

Table 1 Baseline subject characteristics

From: Supervised neuromuscular exercise prior to hip and knee replacement: 12-month clinical effect and cost-utility analysis alongside a randomised controlled trial

 

Intervention group

Control group

 
 

Mean difference (95%CI)

n

84

81

 

Female sex

47 (56%)

45 (56%)

 

Age–years

67.9 (8.6)

66.9 (8.3)

1.08 (−1.52 to 3.67)

BMI–kg/m2

29.6 (4.5)

31.1 (6.1)

−1.41 (−3.05 to 0.24)

Waiting list THA

43 (51%)

41 (51%)

 

Waiting list TKA

41 (49%)

40 (49%)

 

EQ-5D-3L

0.63 (0.15)

0.57 (0.19)

0.06 (0.01 to 0.12)

HOOS/KOOS

 

ADL

50.5 (15.1)

45.6 (16.9)

4.9 (−0.02 to 9.83)

Pain

46.8 (14.3)

42.7 (14.4)

4.0 (−0.39 to 8.46)

Symptoms

49.4 (19.7)

44.6 (18.6)

4.8 (−0.98 to 10.55)

Sport & Recreation

24.6 (17.2)

19.9 (18.2)

4.6 (−0.80 to 10.09)

Quality of life

31.2 (12.1)

28.9 (15.9)

2.3 (−2.01 to 6.60)

  1. Continuous variables are expressed as the mean (SD); non-continuous variables are expressed as the number of patients (%); THA, Total hip arthroplasy; TKA, Total knee arthroplasty; EQ5D-3L, European Quality of Life 5 Dimension 3 Level Health Outcome; HOOS, Hip disability and Osteoarthritis Outcome Score; KOOS, Knee injury and Osteoarthritis Outcome Score; ADL, function in daily living